Puma Biotechnology, Inc. (PBYI)
8.26
-0.14
(-1.61%)
USD |
NASDAQ |
Nov 10, 09:50
Puma Biotechnology Market Cap : 422.11M for Nov. 10, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 09, 2026 | 429.01M |
| November 06, 2026 | 421.60M |
| November 05, 2026 | 499.27M |
| November 04, 2026 | 546.29M |
| November 03, 2026 | 522.27M |
| November 02, 2026 | 520.23M |
| October 30, 2026 | 533.51M |
| October 29, 2026 | 538.62M |
| October 28, 2026 | 542.71M |
| October 27, 2026 | 558.04M |
| October 26, 2026 | 554.46M |
| October 23, 2026 | 563.15M |
| October 22, 2026 | 575.42M |
| October 21, 2026 | 557.02M |
| October 20, 2026 | 549.87M |
| October 19, 2026 | 521.76M |
| October 16, 2026 | 502.34M |
| October 15, 2026 | 537.60M |
| October 14, 2026 | 521.25M |
| October 13, 2026 | 517.16M |
| October 12, 2026 | 525.85M |
| October 09, 2026 | 525.85M |
| October 08, 2026 | 509.49M |
| October 07, 2026 | 501.32M |
| October 06, 2026 | 485.48M |
| Date | Value |
|---|---|
| October 05, 2026 | 494.16M |
| October 02, 2026 | 485.99M |
| October 01, 2026 | 502.85M |
| September 30, 2026 | 507.45M |
| September 29, 2026 | 499.78M |
| September 28, 2026 | 501.83M |
| September 25, 2026 | 499.27M |
| September 24, 2026 | 501.83M |
| September 23, 2026 | 474.23M |
| September 22, 2026 | 501.83M |
| September 21, 2026 | 490.07M |
| September 18, 2026 | 490.59M |
| September 17, 2026 | 486.50M |
| September 16, 2026 | 479.85M |
| September 15, 2026 | 472.70M |
| September 14, 2026 | 467.08M |
| September 11, 2026 | 466.06M |
| September 10, 2026 | 468.61M |
| September 09, 2026 | 462.48M |
| September 08, 2026 | 479.85M |
| September 04, 2026 | 488.03M |
| September 03, 2026 | 480.88M |
| September 02, 2026 | 495.19M |
| September 01, 2026 | 477.81M |
| August 31, 2026 | 465.55M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Olema Pharmaceuticals, Inc. | 631.40M |
| Anika Therapeutics, Inc. | 191.00M |
| ACADIA Pharmaceuticals, Inc. | 3.024B |
| Alnylam Pharmaceuticals, Inc. | 20.89B |
| Savara, Inc. | 1.033B |
Market Cap Related Metrics
| PE Ratio | 18.13 |
| PS Ratio | 1.853 |
| Price to Book Value | 3.047 |
| Price | 8.26 |
| Earnings Yield | 5.52% |
| Operating PE Ratio | 16.42 |